CrCl vs eGFR: Which to Use and When

Use creatinine clearance for drug dosing and eGFR for CKD staging. They estimate related but distinct things, in different units, and are not interchangeable without correction.

What Is the Difference Between CrCl and eGFR?

Creatinine clearance and eGFR both describe how well the kidneys remove waste, but they answer two different questions. Creatinine clearance asks how much creatinine the kidneys cleared — a value used to dose drugs. eGFR asks what the filtration rate is, standardised to body size — a value used to stage disease. The table below sets out the six axes that separate them.

Calculate either: the creatinine clearance calculator or the eGFR calculator.

Different Inputs Change the Answer

The input lists matter clinically. Cockcroft–Gault includes weight, so a patient's body size moves the result; CKD-EPI does not, because it reports a rate already indexed to a standard body surface area. That single difference is why the two numbers can diverge for the same patient, especially at the extremes of body size — see the units section below.

Should You Use CrCl or eGFR for Drug Dosing?

Use creatinine clearance from the Cockcroft–Gault equation for drug dosing. Most renal-dosing studies and FDA drug labels were validated against Cockcroft–Gault CrCl, so it is the value that maps to published thresholds in renal drug dosing. When a label says “adjust the dose if CrCl is below 30 mL/min,” that threshold was set against a Cockcroft–Gault number; substituting an eGFR can move a patient across the cutoff and change the dose. Reserve eGFR for staging.

Why CrCl Overestimates GFR

The kidney tubules secrete a small amount of creatinine in addition to filtering it, so measured creatinine clearance reads slightly higher than true glomerular filtration rate. The gap widens as kidney function falls, because the secreted fraction becomes a larger share of total creatinine output. Read more on tubular secretion.

Accuracy and Validation: Which Number Is “Truer”?

Neither equation measures GFR directly; both estimate it from serum creatinine. CKD-EPI 2021 was developed and calibrated against measured GFR in large modern cohorts, so it is the more accurate estimate of true filtration, particularly near-normal function. Cockcroft–Gault was derived in 1976 from a small cohort and predicts a timed creatinine clearance, which sits above true GFR. The point is not that one is wrong — they target different quantities. For staging, use the value calibrated to GFR (eGFR); for dosing, use the value the dosing studies used (CrCl).

Cockcroft–Gault vs CKD-EPI vs MDRD

For the eGFR-vs-eGFR question, see MDRD vs CKD-EPI; for the same dosing-vs-staging question framed around the two named equations, see Cockcroft–Gault vs CKD-EPI.

Units: mL/min vs mL/min/1.73m²

Creatinine clearance is an absolute rate (mL/min); eGFR is indexed to a 1.73m² body surface area (mL/min/1.73m²). For an average-sized adult the two units are nearly interchangeable. For an unusually large or small patient they are not: a large patient's absolute clearance can exceed the indexed eGFR, and a small patient's can fall below it. To compare them, de-index the eGFR back to absolute mL/min by multiplying by the patient's body surface area divided by 1.73. Use the GFR unit converter to do this — comparing an absolute CrCl with an indexed eGFR without converting is one of the most common dosing errors.

A Worked Comparison

Consider a 75-year-old woman, 50 kg, with a serum creatinine of 1.3 mg/dL. Cockcroft–Gault gives roughly 26 mL/min of creatinine clearance — below the common 30 mL/min dosing threshold, so a renally-cleared drug would be reduced. Her CKD-EPI eGFR is around 40 mL/min/1.73m², which stages her as CKD G3b but, being indexed to a larger standard body size, reads higher than her low-weight absolute clearance. Dosing from the eGFR here would risk overdosing a small, elderly patient. This is precisely why the equation must match the task.

Why the Two Equations Exist at All

It can seem inefficient to keep two estimates of the same kidneys, but each was built for a different job and validated against a different reference. Cockcroft–Gault came first, in 1976, when the practical need was to dose drugs safely; it was fit to predict a timed creatinine clearance and reported in absolute mL/min so that a dose could be matched to a clearance threshold. The eGFR equations came later to answer a population-health question — how to detect, stage, and track chronic kidney disease consistently across people of different sizes — which is why they are indexed to a standard body surface area and calibrated against measured GFR. Different questions produced different tools, and replacing one with the other discards the validation that makes it trustworthy.

Inputs Compared Axis by Axis

The clearest way to keep the two straight is to walk each axis in turn. On output, CrCl estimates clearance of creatinine while eGFR estimates glomerular filtration rate. On units, CrCl is absolute mL/min and eGFR is indexed mL/min/1.73m². On inputs, CrCl uses age, sex, weight, and creatinine while eGFR drops weight. On validation cohort, CrCl rests on 249 hospitalized adults from 1976 and eGFR on large pooled modern cohorts. On accuracy, CrCl overstates true GFR because of tubular secretion while eGFR is calibrated to measured GFR. On primary use, CrCl drives dosing and eGFR drives staging. Six axes, two consistent answers: same kidneys, different lenses.

Common Mistakes to Avoid

Three errors recur. The first is dosing from an eGFR: because labels were validated on Cockcroft–Gault, using an eGFR can push a patient across a dose threshold and cause under- or over-dosing, especially in small, elderly, or low-weight patients. The second is comparing an absolute CrCl with an indexed eGFR without de-indexing, which makes the numbers look discrepant when they are simply in different units — multiply the eGFR by body surface area ÷ 1.73 first, using the GFR unit converter. The third is treating the gap as an error: CrCl is meant to read above true GFR, so a higher CrCl than eGFR is expected, not a sign that one calculation is wrong.

What About MDRD and the Older Equations?

eGFR can be produced by more than one equation. MDRD is the older eGFR formula and underestimates near-normal GFR, so CKD-EPI 2021 is preferred for staging today; that eGFR-vs-eGFR choice is covered in MDRD vs CKD-EPI. None of the eGFR equations replaces Cockcroft–Gault for dosing. For special populations, the equation changes again: children use the bedside Schwartz equation, markedly obese patients may use Salazar–Corcoran, and patients with rapidly changing function are better served by the non-steady-state Jelliffe equation.

Which to Use When: The Verdict

Use Cockcroft–Gault creatinine clearance for drug dosing and CKD-EPI 2021 eGFR for CKD staging. They are not interchangeable: they estimate different quantities, in different units, from different inputs, validated against different references. When the two numbers disagree for one patient, that is expected — read each in its own context rather than forcing them to match. For a low-weight or high-weight patient, always de-index before any direct comparison.

Calculate With Either Method